Why Should I Trust You: Addressing Mistrust in Mainstream Medicine

In April 2026, a growing conversation emerged at the intersection of public health advocacy and vaccine skepticism, spotlighted by emergency physician Craig Spencer’s candid account of engaging with MAHA (Make America Healthy Again) supporters at the Children’s Health Defense Conference in Austin, Texas. His experience, detailed in a STAT essay and revisited on the “First Opinion Podcast” with hosts Brinda Adhikari and Tom W. Johnson, underscores a critical challenge: rebuilding trust in medical institutions amid rising misinformation without compromising scientific integrity. As public health faces renewed scrutiny over vaccine confidence and chronic disease prevention, this dialogue reveals not just a communication gap, but a systemic need for empathetic, evidence-based engagement that meets communities where they are—without conceding ground to disinformation.

Key Clinical Takeaways:

• Vaccine hesitancy persists despite overwhelming evidence, with CDC data showing only 68.2% of U.S. Adults received the 2023–2024 updated COVID-19 vaccine, highlighting gaps in booster uptake even among high-risk groups.
• Engagement rooted in respect—rather than confrontation—can open dialogue, but must be paired with clear, transparent communication about vaccine safety systems like VAERS and the Vaccine Safety Datalink (VSD), which monitor millions of doses annually.
• Trusted messengers, including primary care physicians and community health workers, remain pivotal. studies display patients are 3x more likely to accept vaccines when recommended by their own clinician, per a 2025 JAMA Internal Medicine analysis.

The core issue is not merely skepticism toward vaccines, but a broader erosion of confidence in public health institutions fueled by polarized narratives, historical injustices in medical research, and the rapid spread of unverified claims online. MAHA-aligned groups often frame their concerns around bodily autonomy and perceived overreach, yet frequently conflate correlation with causation—such as linking rising autism diagnoses to vaccine schedules despite decades of refuting evidence. This misattribution distracts from real public health priorities, including rising rates of type 2 diabetes, pediatric obesity, and mental health crises, which MAHA purports to address but often overlooks in favor of ideological fixation on immunization.

Entering Phase III trials for next-generation mRNA vaccines targeting influenza and RSV, the scientific community faces a dual imperative: advance innovation while fortifying public trust. According to the longitudinal study published in The Lancet (2025), vaccine confidence dropped 12 percentage points in the U.S. Between 2020 and 2024, with the steepest declines among adults aged 30–49—a demographic increasingly influenced by social media narratives. Yet, biological mechanisms remain unassailable: mRNA platforms do not alter DNA, degrade rapidly after eliciting an immune response, and have demonstrated safety in over 13 billion doses administered globally since 2020, per WHO pharmacovigilance reports.

“We must stop treating vaccine hesitancy as a knowledge deficit and start seeing it as a trust deficit. People aren’t rejecting science—they’re rejecting systems they feel have failed them. Our job is to rebuild that bridge, not shout across it.”

Funding for ongoing vaccine safety research comes from diverse sources, including the CDC’s Immunization Safety Office and NIH grants such as U01IP001122, which supports the Clinical Immunization Safety Assessment (CISA) Project. Transparency in these efforts is vital—yet often poorly communicated. For instance, the VSD, a collaboration between the CDC and nine integrated healthcare systems, analyzes electronic health records from over 12 million patients annually to detect rare adverse events. Despite its rigor, public awareness of such systems remains low, creating a vacuum filled by misinformation.

This gap presents a clear triage opportunity: individuals navigating vaccine decisions or managing chronic conditions linked to lifestyle factors benefit from structured, compassionate guidance. For patients questioning vaccine safety or seeking personalized prevention strategies, consulting with vetted board-certified primary care physicians ensures care grounded in both evidence, and empathy. Similarly, those exploring MAHA-aligned wellness trends—such as detox protocols or unregulated supplements—should engage with licensed clinical nutritionists to distinguish evidence-based interventions from potentially harmful fads.

On the B2B front, public health agencies and private clinics launching outreach campaigns face complex messaging challenges. Navigating the ethical tightrope of empathetic engagement without amplifying false balance requires specialized expertise. Healthcare organizations are increasingly retaining healthcare compliance attorneys to ensure patient education materials adhere to FDA guidelines on truthful non-promotional content while avoiding inadvertent validation of debunked claims.

The path forward lies not in winning arguments, but in sustaining conversations. As Spencer reflected, changing minds may not be the immediate goal—but fostering spaces where questions are met with patience, not ridicule, can gradually shift the ecosystem. Public health must evolve beyond top-down messaging to embrace community-led initiatives, leveraging trusted local figures—faith leaders, barbershop coordinators, school nurses—to disseminate accurate information in culturally resonant ways.

“Trust is built in teaspoons and lost in gallons. Every respectful conversation, every transparent data share, every clinician who says ‘I don’t know, but let’s find out together’—that’s how we restore credibility.”

As we move through 2026, the integration of behavioral science into vaccine outreach—such as motivational interviewing techniques and narrative-based communication—shows promise. Pilot programs in Ohio and Arizona demonstrating increased HPV vaccine uptake through empathetic counseling models offer scalable blueprints. The solution is not more data alone, but better delivery: meeting skepticism with humility, complexity with clarity, and fear with unwavering, compassionate science.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*